Trademark Overview
On Tuesday, April 1, 2025, a trademark application was filed for ZOLGENSMA INTRATHECAL with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA INTRATHECAL trademark a serial number of 99114521. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, April 1, 2025. This trademark is owned by Novartis AG. The ZOLGENSMA INTRATHECAL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and gene therapy products in the nature of injectable biological preparations for the treatment of genetic, neurological, motor neuron, and neuromuscular diseases, disorders, and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials, sold as a unit, for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials, sold as a unit, for sustained survival motor neuron protein expression being for the treatment of spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis
